Two Sigma Securities’s MacroGenics MGNX Stock Holding History

Two Sigma Securities’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,688	Closed	-$23K	–	1809
2025 Q3	$23K	Buy	+13,688	New	+$22.2K	﹤0.01%	1116

Other funds holding MGNX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Two Sigma Securities's MGNX Position: Q4 2025 in Review

Two Sigma Securities sold out of MacroGenics (MGNX) in Q4 2025, closing a stake of 13,688 shares — an estimated $23K sold.

Two Sigma Securities first reported a position in MGNX in Q3 2025 and held it in 1 quarter. The position peaked at $23K in Q3 2025. 88 funds tracked by Wall St. Rank hold MGNX as of Q4 2025.

Two Sigma Securities reported no remaining MacroGenics position as of Q4 2025 after selling out during the quarter.
Two Sigma Securities sold 13,688 MacroGenics shares in Q4 2025, an estimated $23K.
Two Sigma Securities first reported a position in MacroGenics in Q3 2025 and held it in 1 quarter.
Two Sigma Securities's MacroGenics position peaked at $23K in Q3 2025.
88 funds tracked by Wall St. Rank held MacroGenics as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.